Amendments for: 172-2018-2019-Q4-920200

Current (Jun 1, 2022)

Agreement Value: $1,915,000.00
Agreement: Development of a plant-based candidate combination vaccine for SARS-CoV-2 and seasonal influenza (920200). Jan 1, 2019 - Mar 31, 2023
Description:

Development of a plant-derived candidate universal influenza vaccine ready for clinical development

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Organization: National Research Council Canada
Recipient: Medicago Inc. (For-profit organization)
Location: Quebec, Quebec, CA G1V 3V9
Type: Contribution
Additional Information:

This agreement has been amended 1 time(s). The end date of this agreements has been modified by 90 days. The total amended value is -600,000 dollars.

Federal Riding Name: Louis-Hébert (24044)
Program Name: Industrial Research Assistance Program – Contributions to Firms

Coverage: IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code: 325410

Amendment 02 (Jun 1, 2022)

Agreement Value: $1,915,000.00
Agreement: Development of a plant-based candidate combination vaccine for SARS-CoV-2 and seasonal influenza - Mar 31, 2023
Organization: National Research Council Canada
Recipient: -
Type: -
Additional Information:

This agreement has been amended 1 time(s). The end date of this agreements has been modified by 90 days. The total amended value is -600,000 dollars.

Amendment 01 (Sep 4, 2020)

Agreement Value: $2,515,000.00
Organization: National Research Council Canada
Recipient: -
Type: -
Additional Information:

This agreement has been amended 1 time(s). The end date of this agreements has been modified by 306 days.

Amendment 00

Agreement Value: $2,515,000.00
Agreement: Development of a universal influenza vaccine (920200). Jan 1, 2019 - Feb 28, 2022
Description:

Development of a plant-derived candidate universal influenza vaccine ready for clinical development

Expected Results:

Organization: National Research Council Canada
Recipient: Medicago Inc. (For-profit organization)
Location: Quebec, Quebec, CA G1V 3V9
Type: Contribution
Federal Riding Name: Louis-Hébert (24044)
Program Name: Industrial Research Assistance Program – Contributions to Firms

Coverage: IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code: 325410